<!DOCTYPE html>
<html>
<head>
  <title>Emmanuelle Charpentier – Profile</title>
  <style>
    body { font-family: Arial, sans-serif; margin: 2rem auto; max-width: 960px; line-height: 1.5; }
    aside.infobox { float: right; width: 280px; margin: 0 0 1rem 1.5rem; border: 1px solid #ccc; padding: 0.5rem; font-size: 0.9rem; }
    aside.infobox h3 { text-align: center; margin-top: 0; }
    aside.infobox table { width: 100%; border-collapse: collapse; }
    aside.infobox td { padding: 0.25rem 0; vertical-align: top; }
    h1 { margin-top: 0; }
    footer.categories { font-size: 0.8rem; color: #555; border-top: 1px solid #ddd; padding-top: 0.5rem; margin-top: 2rem; }
  </style>
</head>
<body>
  <h1>Emmanuelle Charpentier</h1>
  <aside class="infobox">
    <h3>Emmanuelle Charpentier</h3>
    <table>
      <tr><td><strong>Full name</strong></td><td>Emmanuelle Marie Charpentier</td></tr>
      <tr><td><strong>Born</strong></td><td>11 December 1968<br>Serrières-sur-Ain, Ain, France</td></tr>
      <tr><td><strong>Nationality</strong></td><td>French</td></tr>
      <tr><td><strong>Occupation(s)</strong></td><td>Microbiologist, Biochemist, Geneticist</td></tr>
      <tr><td><strong>Years active</strong></td><td>1990s–present</td></tr>
      <tr><td><strong>Notable works/roles</strong></td><td>CRISPR-Cas9 gene-editing technology researcher</td></tr>
      <tr><td><strong>Website</strong></td><td><a href="https://cmbe.christian-marie.com/">cmbe.christian-marie.com</a></td></tr>
    </table>
  </aside>
  <p>Emmanuelle Marie Charpentier is a French microbiologist and geneticist renowned for her pioneering work on CRISPR-Cas9 gene-editing technology. Her research has transformed biological sciences and holds promise for medical, agricultural, and industrial applications. Along with colleagues, she uncovered the mechanisms of the bacterial immune system underlying CRISPR, leading to the development of precise gene editing tools widely used today. Her contributions have earned numerous awards and international recognition for advancing genome editing and molecular biology.</p>
  
  <h2>Early life and education</h2>
  <p>Charpentier was born in 1968 in Serrières-sur-Ain, France. She developed an early interest in microbiology and received her doctorate in microbiology at the Pasteur Institute in Paris. Her interest in bacterial immune systems and genetics led her to pursue postdoctoral research internationally, including positions at the University of Vienna and the Umeå University in Sweden. Her academic background laid the foundation for her groundbreaking discoveries in bacterial adaptive immunity and gene editing technology.</p>
  
  <h2>Career</h2>
  <p>Charpentier’s academic and research career began in the 1990s. Her focus on bacterial immune mechanisms led her to investigate the function of CRISPR sequences in bacteria. In collaboration with Jennifer Doudna, she elucidated the molecular basis of CRISPR-Cas9 as a programmable endonuclease capable of targeted DNA cleavage. Their work, published in 2012, revolutionized genome editing, enabling scientists worldwide to modify genes precisely and efficiently. Since then, she has held faculty positions at the Max Planck Institute and the Berlin Institute of Medical Systems Biology, promoting further innovations in genome engineering.</p>
  
  <h2>Notable works and projects</h2>
  <p>Her seminal 2012 publication introduced CRISPR-Cas9 as a versatile gene-editing tool. This technology has been applied in medicine to develop gene therapies, in agriculture to create genetically modified crops, and in basic research for functional genomics studies. Charpentier’s ongoing projects focus on improving the specificity and safety of CRISPR-based tools, as well as exploring new applications in synthetic biology. Her research continues to drive progress in precision medicine and sustainable food production.</p>
  
  <h2>Personal life</h2>
  <p>Charpentier maintains a modest public profile; details about her personal life are largely private. She has expressed passion for science communication and mentoring young scientists. She has received honors from numerous scientific societies and continues to advocate for responsible application of gene-editing technologies. Her dedication to advancing science is driven by the potential of genetic tools to solve global challenges in health and sustainability.</p>
  
  <h2>Awards and honours</h2>
  <p>Charpentier has received multiple prestigious awards, including the 2020 Nobel Prize in Chemistry, shared with Jennifer Doudna, for their development of CRISPR-Cas9 gene editing. She has also been awarded the Breakthrough Prize in Life Sciences, the Körber European Science Prize, and the.basically multiple national and international recognitions for her scientific achievements. Her work has been acknowledged as a transformative milestone in molecular biology.</p>
  
  <h2>Legacy and impact</h2>
  <p>Emmanuelle Charpentier’s discovery of the CRISPR-Cas9 system has revolutionized biotechnology and genetics. Her contributions have enabled precise genetic modifications across multiple fields, catalyzing advancements in medicine, agriculture, and bioengineering. The technology she helped popularize has accelerated research and therapeutic development, offering hope for treating genetic diseases and improving crop resilience. Her career exemplifies how fundamental scientific research can lead to transformative societal impact and ethical considerations in genome editing.</p>
  
  <h2>References</h2>
  <ol>
    <li>“Emmanuelle Charpentier — Nobel Lecture.” NobelPrize.org. Retrieved 12 May 2025.</li>
    <li>Jinek, M., et al. (2012). “A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity.” Science, 337(6096), 816–821.</li>
    <li>“CRISPR–Cas9 gene editing—The beginning of a revolution.” Nature. Retrieved 12 May 2025.</li>
    <li>“Emmanuelle Charpentier Biography.” National Academy of Sciences. Retrieved 12 May 2025.</li>
    <li>“Körber European Science Prize 2018 awarded to Emmanuelle Charpentier and Jennifer Doudna.” Körber Foundation. Retrieved 12 May 2025.</li>
  </